Pennsylvania HB377 prohibits the manufacture, delivery, or possession of tianeptine without proper registration.
Pennsylvania HB377 amends the Controlled Substance, Drug, Device and Cosmetic Act to add tianeptine to the list of prohibited substances. It prohibits the manufacture, delivery, or possession of tianeptine or its derivatives by unregistered individuals or practitioners. Violation of this provision is classified as a felony, punishable by up to five years in prison, a fine of up to $15,000, or both. The act takes effect immediately upon enactment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.